CloseLog In

Access to this feature requires a Personal Account.

skip to the content

MD Consult brings the leading medical resources together into one integrated online service to help you efficiently find answers to pressing clinical questions and make better treatment decisions.


Sign up now for a free 30-day trial!

Email to Colleague Print Version

Use of this content is subject to the Terms and Conditions of the MD Consult web site.

Chapter 2 – Medication use

Rebecca J. Beyth, M.D., M.Sc.,
Ronald I. Shorr, M.D., M.S.

Summary Points for the Primary Care Physician

      In older persons, the relative increase in body fat and the decrease in lean body mass alter drug distribution so that fat-soluble drugs are distributed more widely and water-soluble drugs are distributed less widely.
      The cytochrome P450 (CYP3A) hepatic metabolism of medications may result in a new medication causing a dangerous side effect of another medication, which was previously safely prescribed.
      An important pharmacokinetic change that occurs in persons of advanced age is that of reduced renal drug elimination.
      The sensitivity to drug side effects may either increase or decrease with increasing age.
      The physician must understand that protocol medicine may not be relevant to a heterogeneous older population.
      Nonadherence to medications is more common in older patients because they simply are prescribed more medications than younger patients.
      Poor communication …



You are currently viewing a Preview of MD Consult

For full access to this content, log in or start a subscription. We also offer a 30-day free trial!


A subscription to MD Consult provides complete access to leading medical reference resources including Books, Journals, The Clinics of North America, Drug Information, Patient Education, Practice Guidelines, News, Images, and CME. Sign up for our 30-day free trial!